American Health Council Names Matilde Inglese, MD, Ph.D. to Education Board

NEW YORK, April 24, 2017 -- Dr. Matilde Inglese, Associate Professor of Neurology, Radiology and Neuroscience at the Icahn School of Medicine at Mount Sinai has been selected to join the Education Board at the American Health Council. She will be sharing her knowledge and expertise on Neuroscience, Neuroimaging and Multiple Sclerosis.  

As an Internationally recognized expert in the field of neuroimaging in demyelinating disorders, Dr. Matilde Inglese offers valuable insight in her role as the Associate Professor of Neurology, Radiology and Neuroscience at the Icahn School of Medicine at Mount Sinai for over fifteen years, Dr. Inglese’s day-to-day responsibilities include clinical research of Multiple Sclerosis patients using neuroimaging techniques. With support from the National Institute of Health, her research is geared towards the development and application of new structural and functional magnetic resonance imaging techniques at high and ultra-high field strength to analyze neurological diseases.

Upon receipt of a medical degree magna cum laude from the University of Genoa, Italy in 1992, Dr. Inglese completed her residency at the University of Genoa in 1998.  In 1999, she completed a post-doctoral fellowship in Neuroimaging at San Raffaele Hospital, Milan, Italy. To further develop her professional career, she completed a fellowship in Radiology at the New York University in 2002. In 2004, Dr. Inglese obtained her PhD from the University of Genoa.

Prior to her role as an Associate Professor of Neurology, Radiology and Neuroscience, at the Icahn School of Medicine at Mount Sinai in New York, Dr. Inglese joined the NYU faculty as an Associate Professor of Radiology, Neurology and Biomedical Imaging at New York University in 2011.

Her interest in the field of Neurology began while in Italy, when she felt that very little was known about the pathophysiology of multiple sclerosis and the available treatments were only partially efficacious or not efficacious at all in subgroups of patients. Dr. Inglese thought that understanding how the disease progressed and why some patients have benefit from treatment and other not would eventually lead to improvement of patients’ care and quality of life.

Dr. Inglese has authored over a hundred and fifty publications and received multiple grant funding from the National Institute for Neurological Disorders and Stroke, the National Multiple Sclerosis Society and the Congressionally Directed Medical Research Program in Multiple Sclerosis. Her publications have been featured in peer-reviewed journals such as the Lancet, Lancet Neurology, Annals of Neurology, Brain and Neurology. She has served on the editorial board of peer-reviewed journals and on grant advisory panels for the National Institute of Health, the National Multiple Sclerosis Society and for several international funding agencies.

Dr. Inglese maintains affiliations with The American Academy of Neurology, International Society of Magnetic Resonance in Medicine, and the National Institute of Health study sections.

In her free time, Dr. Inglese enjoys reading, bicycling and swimming. Her charitable organizations involvement includes participating in marathons for Multiple Sclerosis, completing peer reviews for the MS Foundation, and volunteering with MS Hope for a Cure.

Considering the future, Dr. Inglese hopes to understand the pathophysiology of Multiple Sclerosis progression and contribute to provide new and effective biomarkers to monitor disease progression and response to treatment.

For more information, please contact:
Elizabeth Moore
American Health Council
Hauppauge, NY United States
Phone: 1-212-390-0214
Email: [email protected]